Profound Medical (PROF) Net Income towards Common Stockholders (2024 - 2026)

Profound Medical's Net Income towards Common Stockholders history runs 3 years deep, the most recent figure standing at $7.1 million for Q1 2026.

• In Q1 2026, Net Income towards Common Stockholders fell 34.23% year-over-year to $7.1 million; the TTM figure through Mar 2026 stood at $60.3 million (up 33.73% YoY), while the FY2025 annual figure was $42.6 million, up 53.04% from the prior year.
• Net Income towards Common Stockholders was $7.1 million for Q1 2026 at Profound Medical, down from $77.0 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $77.0 million in Q4 2025 to a low of -$15.7 million in Q2 2025.
• Historically, Net Income towards Common Stockholders has averaged $11.0 million across 3 years, with a median of -$6.6 million in 2024.
• Biggest YoY gain for Net Income towards Common Stockholders was 262.85% in 2025; the steepest drop was 126.84% in 2025.
• A 3-year view of Net Income towards Common Stockholders shows it stood at $50.7 million in 2024, then jumped by 51.85% to $77.0 million in 2025, then tumbled by 90.84% to $7.1 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at $7.1 million (Q1 2026), $77.0 million (Q4 2025), and -$8.0 million (Q3 2025), per Business Quant data.